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Orientation is a dimension much
studied in visual neuroscience. Many
single cells in the visual cortex
respond to lines or edges in specific
orientations, and in monkey cortex
these cells are specific for lines
within ±20° of the preferred
orientation.
One class of illusion, involving
perception of orientation, can direct
us towards interpretations of neural
function (in this series, referred to as
neuro-signs). The horizontal parallel
lines in the image below do not
appear so — they look to be
alternately inclined clockwise and
anticlockwise. If the horizontal lines
intersected the curved ones
orthogonally, they would appear
parallel. Thus, the illusion occurs
when horizontal lines intersect near-
horizontals. This indicates that the
perception of orientation is based
not only on the orientation
selectivity of a particular cell, but
also on interactions with cells with
similar orientation selectivities.
The illusion could point to one of
several neuro-signs: the range of
active orientation-selective cells
might be biased by the surrounding
contours; the receptive field (the
region of the retina that can change
the activity of a group of nerve cells
when light falls on it) properties of
particular cells might be modified by
their immediate context; or cells
with similar receptive field
orientations could inhibit one
another.
In addition to the simultaneous
biasing of perceived orientation,
there are tilt after-effects:
observation of inclined lines for
some seconds results in
subsequently viewed vertical lines
appearing tilted in the opposite
direction. There are two distortions
in the circular image above — tilt
and displacement. The ‘Zöllner
illusion’ is the apparent tilt of the
fine vertical lines because of their
intersection with the thicker
inclined lines. Indeed, the vertical
line segments do not even seem to
be aligned, an effect that is called
the ‘Poggendorff illusion’.
Both illusions could be due to
the same process: the interaction
between orientation-selective cells
results in acute angles appearing
larger than they are. The short
vertical line segments then look
inclined anticlockwise, which in
turn makes them appear misaligned.
Usually, orientation illusions are
based on interactions between
contours of similar orientation. The
coloured image below is composed
of only vertical and horizontal lines,
although the verticals do not appear
so. Some squares of the
checkerboard pattern are darker
than others, and they form a
horizontal zig-zag pattern. This
results in the lighter squares
surrounded by three darker ones
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looking smaller than those with two
or no neighbouring dark squares,
which in turn leads to the splayed
appearance of the vertical lines.
Typically, orientation selectivity
is deduced from studies of monkey
cortical cells and the properties of
illusions from human psychophysics,
then correlations between the two
are sought. Such simple
manifestations of neuro-signs are,
however, only correlations, and the
link between correlation and
causation is notoriously tenuous,
particularly when crossing species.
Increasingly, studies are measuring
both perception and neurophysiology
in the same animals so that this link
can be strengthened. The neuro-
signs will direct us more clearly when
neural interactions between
orientation-selective cells to complex
patterns containing many
orientations are better understood.
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The Sanger Centre
What is it famous for? Being one of
the main players in the race to
sequence the human genome. The
Sanger Centre has generated
one-third of all the sequence
produced to date in the Human
Genome Project, and is the biggest
single provider of public domain
sequence information in the world —
with the emphasis on the public.
Where is it? In the back of beyond, on
the Wellcome Trust Genome Campus
at Hinxton in rural Cambridgeshire,
UK (see http://www.sanger.ac.uk). The
centre was established jointly by the
Wellcome Trust and the UK Medical
Research Council (MRC) in 1992. It
is, naturally, named after the double
Nobel laureate Fred Sanger, who
developed a method for reading DNA
sequences essentially the same as that
used today.
How did it come to be? A happy
coincidence of expertise from the
nematode genome sequencing
project (pioneered by John Sulston at
the MRC Laboratory of Molecular
Biology in Cambridge and Bob
Waterston at Washington University
in St Louis, USA) and an injection of
funds from the UK’s Wellcome Trust
(see Curr Biol 1998, 8:R330).
What is it like? It’s a hi-tech rural
idyll. Surrounded by 55 acres of
parkland, the state-of-the art
building features a staircase
representing a DNA spiral and an
electronic display of the number of
bases sequenced, which ticks over at
dizzying speed. At the heart of the
operation is an enormous room
containing row upon row of
automated sequencers, which feed
data to banks of computers.
Is there any danger of feeling isolated?
The 350 Sanger Centre staff share
the Genome Campus with 150
members of the European
Bioinformatics Institute and the
MRC Human Genome Mapping
Project Resource Centre. And —
perhaps in a bid to become the Cold
Spring Harbor of Europe — Hinxton
Hall, the eighteenth century country
house at the centre of the original
estate, has been turned into a
conference centre. (In place of
beaches and fresh lobster, it offers a
lake and a good pub in the nearby
village.) There are also plans to
increase the critical mass of biologists
by creating a ‘biopark’ on the site.
Is it financially stable? In
1995, the Wellcome Trust
made a commitment to fund
the sequencing of one-sixth
of the human genome (at
least 500 million bases) at the
Sanger Centre, to the tune of £95
million. This May, the Trust
announced an additional £110
million over the next seven years, to
allow the Centre to sequence
one-third of the genome by 2005.
What’s the hurry? The major players
in the Human Genome Project (a
loose conglomerate of like-minded
genome research organisations that
includes the US National Institutes
of Health and the MRC) have deep
concerns about the wholesale
patenting of sequences, which many
biotech companies argue they must
do to protect their investment in
sequencing. The Sanger Centre’s
philosophy of open access to
sequence information has brought
its director, John Sulston, into
conflict with the commercial world,
most notably recently with Craig
Venter’s new company, formed to
generate a partial sequence of the
entire human genome by 2001 (see
Curr Biol 1998, 8:R440).
How does the sequence  information get
published? New sequences from the
Centre are directed to the nucleotide
sequence database of the European
Bioinformatics Institute daily at
2.00am local time. The EBI web site
(http://www.ebi.ac.uk) sees roughly
100,000 hits a day.
What will the Centre do once the human
sequence is completed? Carry on
sequencing. Ongoing projects
include Caenorhabditis elegans,
Neisseria meningitidis, Plasmodium
falciparum, bits of Drosophila
melanogaster … and on ad infinitum.
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This is the third in a short series of
articles by Nicholas Wade, describing
some common visual illusions.
